scholarly article | Q13442814 |
P50 | author | Laura Herrero | Q31229237 |
Joan Francesc Mir | Q41464635 | ||
Dolors Serra Cucurull | Q41464641 | ||
Paula Mera | Q84817655 | ||
Maria Ida Malandrino | Q114438455 | ||
P2860 | cites work | Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 |
Obesity, Inflammation, and Insulin Resistance | Q22250939 | ||
Positional cloning of the mouse obese gene and its human homologue | Q22251285 | ||
BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions | Q24321265 | ||
SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation | Q24321658 | ||
Nuclear receptor corepressor RIP140 regulates fat accumulation | Q24561531 | ||
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity | Q24595845 | ||
Identification and importance of brown adipose tissue in adult humans | Q24632425 | ||
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease | Q24633352 | ||
How mitochondria produce reactive oxygen species | Q24643882 | ||
Identification of a physiologically relevant endogenous ligand for PPARalpha in liver | Q24653691 | ||
Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets | Q24683319 | ||
Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology | Q27860991 | ||
A novel brain-expressed protein related to carnitine palmitoyltransferase I | Q28206878 | ||
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus | Q28254114 | ||
Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway | Q28348167 | ||
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers | Q28378616 | ||
Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese | Q28510931 | ||
UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality | Q28513102 | ||
Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production | Q28566853 | ||
Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals | Q28568642 | ||
Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
Identification of conserved amino acid residues in rat liver carnitine palmitoyltransferase I critical for malonyl-CoA inhibition. Mutation of methionine 593 abolishes malonyl-CoA inhibition | Q28579126 | ||
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis | Q28588558 | ||
Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance | Q37105295 | ||
ATF6 modulates SREBP2-mediated lipogenesis. | Q37260315 | ||
Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. | Q37271487 | ||
Characteristics and mechanisms of hypothalamic neuronal fatty acid sensing | Q37337599 | ||
Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species | Q37363614 | ||
Acetylation of mitochondrial proteins | Q37475301 | ||
Role of lipid-derived mediators in skeletal muscle insulin resistance. | Q37551374 | ||
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective | Q37670371 | ||
Nonalcoholic fatty liver disease: pathology and pathogenesis | Q37676210 | ||
JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction | Q37725556 | ||
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection | Q37739949 | ||
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade | Q28610414 | ||
Increased oxidative stress in obesity and its impact on metabolic syndrome | Q29012150 | ||
Cold-activated brown adipose tissue in healthy men | Q29547382 | ||
Brown adipose tissue: function and physiological significance | Q29547448 | ||
Obesity induces a phenotypic switch in adipose tissue macrophage polarization | Q29547686 | ||
Functional brown adipose tissue in healthy adults | Q29547687 | ||
Steatohepatitis: a tale of two "hits"? | Q29547771 | ||
Hydroperoxide metabolism in mammalian organs | Q29614205 | ||
Macrophages, inflammation, and insulin resistance | Q29614351 | ||
Sirtuins in mammals: insights into their biological function | Q29615248 | ||
High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity | Q29615454 | ||
Mitochondrial dysfunction and type 2 diabetes | Q29617913 | ||
The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis | Q29618429 | ||
Unexpected evidence for active brown adipose tissue in adult humans | Q29619030 | ||
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease | Q29619334 | ||
Adipocytes as regulators of energy balance and glucose homeostasis | Q29619448 | ||
Reactive oxygen species have a causal role in multiple forms of insulin resistance | Q29619831 | ||
Mechanisms for insulin resistance: common threads and missing links | Q29620447 | ||
Lipid content in the musculature of the lower leg assessed by fat selective MRI: intra- and interindividual differences and correlation with anthropometric and metabolic data | Q30770149 | ||
A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle | Q31833512 | ||
Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation | Q33238478 | ||
Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity | Q33589062 | ||
Inflammation and adipose tissue macrophages in lipodystrophic mice | Q33591836 | ||
Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway | Q33661644 | ||
Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. | Q33762194 | ||
Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice | Q33782682 | ||
Cellular bioenergetics as a target for obesity therapy | Q33894407 | ||
Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol 3-kinase-dependent pathway | Q33901770 | ||
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes | Q33918445 | ||
Reactive oxygen species enhance insulin sensitivity | Q33941647 | ||
Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet | Q34016567 | ||
Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance | Q34204941 | ||
SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome | Q34209480 | ||
Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet | Q34275922 | ||
Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosis | Q34299225 | ||
Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide | Q34367006 | ||
Lipid-induced insulin resistance: unravelling the mechanism | Q34370958 | ||
Forkhead box o as a sensor, mediator, and regulator of redox signaling. | Q37772177 | ||
Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities | Q37802379 | ||
Brain lipid sensing and nervous control of energy balance | Q37824009 | ||
Uncoupling proteins and the control of mitochondrial reactive oxygen species production | Q37901603 | ||
Endoplasmic reticulum stress, obesity and diabetes | Q37926034 | ||
Current updates in the medical management of obesity. | Q37995649 | ||
Anti-obesity drugs: a review about their effects and their safety | Q37996099 | ||
Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. | Q38022223 | ||
Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation | Q38303256 | ||
Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice | Q38351927 | ||
Immunometabolism: an emerging frontier | Q38876919 | ||
Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis | Q39275872 | ||
More than satiety: central serotonin signaling and glucose homeostasis | Q39676645 | ||
Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells | Q39917673 | ||
The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. | Q39982206 | ||
Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance | Q40028148 | ||
CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance | Q40216131 | ||
Fatty acids induce L-CPT I gene expression through a PPARalpha-independent mechanism in rat hepatoma cells | Q40370246 | ||
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity | Q40379756 | ||
Redox regulation of protein tyrosine phosphatases by hydrogen peroxide: detecting sulfenic acid intermediates and examining reversible inactivation | Q40745756 | ||
Insulin regulates enzyme activity, malonyl-CoA sensitivity and mRNA abundance of hepatic carnitine palmitoyltransferase-I. | Q41295267 | ||
The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells | Q41743893 | ||
Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. | Q41807977 | ||
Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism | Q41857449 | ||
Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. | Q41913346 | ||
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. | Q42033681 | ||
UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals | Q42065664 | ||
Flux control exerted by mitochondrial outer membrane carnitine palmitoyltransferase over beta-oxidation, ketogenesis and tricarboxylic acid cycle activity in hepatocytes isolated from rats in different metabolic states | Q42081081 | ||
Oxidant stress and skeletal muscle glucose transport: roles of insulin signaling and p38 MAPK. | Q42499381 | ||
Digging deeper into obesity | Q42741873 | ||
Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase | Q42814174 | ||
Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 alpha activation by hypothalamic PI3K-dependent mechanism | Q43288025 | ||
Regulation of carnitine palmitoyltransferase by insulin results in decreased activity and decreased apparent Ki values for malonyl-CoA. | Q43413499 | ||
Central administration of oleic acid inhibits glucose production and food intake | Q43867506 | ||
The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation. | Q43940116 | ||
AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats | Q44155454 | ||
Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity. | Q44272716 | ||
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test | Q44627897 | ||
UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction | Q44653224 | ||
Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance | Q44760628 | ||
Insulin resistance. Prosperity's plague. | Q45927417 | ||
Liver fat and lipid oxidation in humans. | Q45929386 | ||
C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight | Q46191269 | ||
Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis | Q34527222 | ||
Developmental origin of fat: tracking obesity to its source. | Q34705822 | ||
Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake | Q34706061 | ||
The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin | Q34718745 | ||
Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. | Q34733232 | ||
Metabolic sensors: viewing glucosensing neurons from a broader perspective | Q34738773 | ||
Oxidative stress and the etiology of insulin resistance and type 2 diabetes | Q34768229 | ||
Adipose tissue remodeling and obesity | Q35015740 | ||
Sixteen years and counting: an update on leptin in energy balance | Q35015746 | ||
Circadian rhythms, sleep, and metabolism | Q35015762 | ||
Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production | Q35197888 | ||
Sirtuin 1 in lipid metabolism and obesity | Q35214969 | ||
Therapeutic approaches to target inflammation in type 2 diabetes | Q35581498 | ||
Human fatty liver disease: old questions and new insights | Q35588477 | ||
Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender | Q35592126 | ||
Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? | Q35596985 | ||
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle | Q35676919 | ||
Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity | Q35768964 | ||
Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes | Q35780260 | ||
The ins and outs of mitochondrial dysfunction in NASH. | Q35821156 | ||
NADPH oxidase-derived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes | Q35879950 | ||
Lipid-induced mitochondrial stress and insulin action in muscle | Q35947486 | ||
Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity | Q36082167 | ||
Hypothalamic sensing of fatty acids | Q36108719 | ||
Regulation of hypothalamic malonyl-CoA by central glucose and leptin. | Q36288540 | ||
Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease | Q36450812 | ||
Modulation of glucose transport in skeletal muscle by reactive oxygen species | Q36643399 | ||
High expression of a novel carnitine palmitoyltransferase I like protein in rat brown adipose tissue and heart: isolation and characterization of its cDNA clone | Q36701696 | ||
Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function | Q36777865 | ||
Neurobiology of feeding and energy expenditure | Q36824059 | ||
Insulin sensitivity: modulation by nutrients and inflammation | Q36848937 | ||
Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease | Q36856713 | ||
Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease | Q36910684 | ||
Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease | Q37024621 | ||
Sites of generation of reactive oxygen species in homogenates of brain tissue determined with the use of respiratory substrates and inhibitors. | Q46568844 | ||
"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis | Q46626411 | ||
Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content | Q46933158 | ||
Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss | Q47254568 | ||
Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study | Q47321369 | ||
Effects of high fat-feeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyme A esters in liver and skeletal muscle | Q47412626 | ||
Lipid sensing and insulin resistance in the brain | Q48531280 | ||
Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats. | Q50534857 | ||
GH does not modulate the early fasting-induced release of free fatty acids in mice. | Q51364932 | ||
Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. | Q51379331 | ||
Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. | Q52523762 | ||
Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. | Q54332121 | ||
Type I iodothyronine 5'-deiodinase mRNA and activity is increased in adipose tissue of obese subjects. | Q54369689 | ||
Role of reactive oxygen species-related enzymes in neuropeptide y and proopiomelanocortin-mediated appetite control: a study using atypical protein kinase C knockdown. | Q54380190 | ||
Maximal perfusion of skeletal muscle in man. | Q54444608 | ||
Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. | Q54645541 | ||
Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle | Q54986901 | ||
Adipose tissue as an endocrine organ | Q57257904 | ||
Setting the Tone: Reactive Oxygen Species and the Control of Appetitive Melanocortin Neurons | Q57912919 | ||
T-ing up inflammation in fat | Q58197131 | ||
Free radicals and tissue damage produced by exercise | Q67231917 | ||
The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization | Q70196543 | ||
Cyclic AMP and fatty acids increase carnitine palmitoyltransferase I gene transcription in cultured fetal rat hepatocytes | Q71130146 | ||
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells | Q71148397 | ||
Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content | Q72371468 | ||
Regulation of rat liver acetyl-CoA carboxylase. Regulation of phosphorylation and inactivation of acetyl-CoA carboxylase by the adenylate energy charge | Q72420028 | ||
Exercise training increases lipid metabolism gene expression in human skeletal muscle | Q74308831 | ||
Steady state changes in mitochondrial electrical potential and proton gradient in perfused liver from rats fed a high fat diet | Q74453044 | ||
UCP1 deficiency increases susceptibility to diet-induced obesity with age | Q81797596 | ||
Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis | Q82254642 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
mitochondrion | Q39572 | ||
fatty acid | Q61476 | ||
P304 | page(s) | 269-284 | |
P577 | publication date | 2012-10-05 | |
P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
P1476 | title | Mitochondrial fatty acid oxidation in obesity | |
P478 | volume | 19 |
Q64946819 | A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. |
Q39015357 | Appetite responses to high-fat meals or diets of varying fatty acid composition: a comprehensive review |
Q37608412 | Association between pterygium and obesity status in a South Korean population |
Q48042688 | Body condition score prior to parturition is associated with plasma and adipose tissue biomarkers of lipid metabolism and inflammation in Holstein cows. |
Q47913705 | Body mass index associates with white matter microstructure in bipolar depression. |
Q50043583 | CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. |
Q44992939 | Chickens from lines selected for high and low body weight show differences in fatty acid oxidation efficiency and metabolic flexibility in skeletal muscle and white adipose tissue |
Q89882438 | Cube natural sea salt ameliorates obesity in high fat diet-induced obese mice and 3T3-L1 adipocytes |
Q102055044 | Dyslipidemia, insulin resistance, and impairment of placental metabolism in the offspring of obese mothers |
Q58577025 | Effect of C fullerene nanoparticles on the diet-induced obesity in rats |
Q46365233 | Effect of under- and overfeeding on sheep and goat milk and plasma enzymes activities related to oxidation. |
Q45073386 | Epigenetic reprogramming in metabolic disorders: nutritional factors and beyond |
Q52564585 | Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity-a pilot study. |
Q26744147 | Fatty acid metabolism and the basis of brown adipose tissue function |
Q89925927 | Gene-Diet Interactions: Dietary Rescue of Metabolic Defects in spen-depleted Drosophila melanogaster |
Q33615881 | Genomic Evidence for Bacterial Determinants Influencing Obesity Development |
Q48112232 | Ghrelin Causes a Decline in GABA Release by Reducing Fatty Acid Oxidation in Cortex. |
Q99365598 | Lactobacillus fermentum promotes adipose tissue oxidative phosphorylation to protect against diet-induced obesity |
Q59800592 | Lipid Metabolic Reprogramming in Hepatocellular Carcinoma |
Q92195093 | Mechanisms of obesity-induced metabolic and vascular dysfunctions |
Q87634459 | Metabolic adaptations in skeletal muscle, adipose tissue, and whole-body oxidative capacity in response to resistance training |
Q35115065 | Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice. |
Q99239547 | Mitochondrial destiny in type 2 diabetes: the effects of oxidative stress on the dynamics and biogenesis of mitochondria |
Q33850305 | Mutations in mitochondrial tRNA genes may be related to insulin resistance in women with polycystic ovary syndrome |
Q35559692 | Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats |
Q35089868 | Nitric oxide and mitochondria in metabolic syndrome. |
Q46301919 | Obesity in Women: Insights for the Clinician. |
Q53703048 | Obesity, Metabolic Syndrome, and Musculoskeletal Disease: Common Inflammatory Pathways Suggest a Central Role for Loss of Muscle Integrity. |
Q28088325 | Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies |
Q46368448 | Obesity, bariatric surgery and oxidative stress |
Q36913776 | Obesity-associated oxidative stress: strategies finalized to improve redox state |
Q90192874 | Plant Extracts and Reactive Oxygen Species as Two Counteracting Agents with Anti- and Pro-Obesity Properties |
Q37474410 | Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes |
Q30363035 | Regulation of obesity and insulin resistance by nitric oxide |
Q64062113 | Role of Arginase 2 in Systemic Metabolic Activity and Adipose Tissue Fatty Acid Metabolism in Diet-Induced Obese Mice |
Q46266754 | Role of mitochondria and mitochondria targeted agents in non-alcoholic fatty liver disease. |
Q96954709 | Scaffold Implant Into the Epididymal Adipose Tissue Protects Mice From High Fat Diet Induced Ectopic Lipid Accumulation and Hyperinsulinemia |
Q90089057 | Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology |
Q46876775 | Soybean flour induces a greater increase of the antioxidant defenses in rats fed with a normocaloric diet compared with a hypercaloric diet. |
Q34412057 | Targeting mitochondrial alterations to prevent type 2 diabetes--evidence from studies of dietary redox-active compounds |
Q92596460 | The Effects of Maternal Obesity on Porcine Placental Efficiency and Proteome |
Q45462968 | The Implication of PGC-1α on Fatty Acid Transport across Plasma and Mitochondrial Membranes in the Insulin Sensitive Tissues. |
Q33831711 | The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease |
Q64963377 | The multifaceted contributions of mitochondria to cellular metabolism. |
Q47333902 | Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress |
Q37397352 | α-MSH and Foxc2 promote fatty acid oxidation through C/EBPβ negative transcription in mice adipose tissue |
Search more.